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Abstract
Risk prediction that capitalizes on emerging genetic findings holds great promise for improving public health and
clinical care. However, recent risk prediction research has shown that predictive tests formed on existing common
genetic loci, including those from genome-wide association studies, have lacked sufficient accuracy for clinical use.
Because most rare variants on the genome have not yet been studied for their role in risk prediction, future
disease prediction discoveries should shift toward a more comprehensive risk prediction strategy that takes into
account both common and rare variants. We are proposing a collapsing receiver operating characteristic (CROC)
approach for risk prediction research on both common and rare variants. The new approach is an extension of a
previously developed forward ROC (FROC) approach, with additional procedures for handling rare variants. The
approach was evaluated through the use of 533 single-nucleotide polymorphisms (SNPs) in 37 candidate genes
from the Genetic Analysis Workshop 17 mini-exome data set. We found that a prediction model built on all SNPs
gained more accuracy (AUC = 0.605) than one built on common variants alone (AUC = 0.585). We further
evaluated the performance of two approaches by gradually reducing the number of common variants in the
analysis. We found that the CROC method attained more accuracy than the FROC method when the number of
common variants in the data decreased. In an extreme scenario, when there are only rare variants in the data, the
CROC reached an AUC value of 0.603, whereas the FROC had an AUC value of 0.524.
Background
The completion of hundreds of genome-wide associa-
tion studies has brought numerous novel disease sus-
ceptibility loci to light. Yet for many diseases the
common variants that have been identified explain only
a small proportion of disease heritability. Additional
genetic variants, including rare variants and gene-gene
or gene-environment interactions, remain uncovered.
Among these, great attention has been given to the rare
variants. Current genome-wide association studies
include only single-nucleotide polymorphisms (SNPs)
with a minor allele frequency (MAF) greater than 5%
[1,2]. Within the next few years, whole-genome sequen-
cing will produce millions of rare variants, with the
expectation that some of them might explain part of the
missing heritability. In fact, experimental studies have
already shown that rare variants are associated with
complex diseases, such as obesity [3], schizophrenia [4],
and colorectal cancer [5].
The uncovered rare variants, particularly those that
are yet to be identified by future whole-genome sequen-
cing studies, can be combined with the known common
variants and clinical risk factors for more accurate dis-
ease prediction. However, few approaches are available
for assessing the combined effect of both common and
rare variants in early disease prediction. Statistical
approaches, such as the collapsing approach [6] and the
weighting approach [7], have recently been proposed to
assess the association of rare variants with disease.
The collapsing approach first combines all rare var-
iants into a single common variant and then analyzes it
with other common variants using multivariate test sta-
tistics. Although this approach was originally proposed
for genetic association studies, the idea can be used for
genetic risk prediction research as well. We here
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(CROC) approach for risk prediction research that con-
siders both common variants and rare variants. The new
approach is an extension of the previously proposed for-
ward receiver operating characteristic (FROC) approach,
which was developed using optimal features of the likeli-
hood ratio rule [8,9]. A multistage collapsing procedure
is added to the FROC approach to facilitate its use in
sequencing data composed of both common and rare
variants.
Methods
FROC approach
The receiver operating characteristic (ROC) curve is
commonly used in genetic risk prediction research to
evaluate the accuracy of a risk prediction model. The
ROC curve plots the sensitivity of a prediction model
against its specificity by continuously changing the cut-
off points over the whole range of possible outcomes.
When the ROC curve is formed on the likelihood ratio
(LR), which is defined as the ratio of the frequency of
a particular test outcome in case subjects to that in
control subjects, it attains the maximum performance
at each cutoff point. The corresponding one-dimen-
sional summary accuracy index, the area under the
ROC curve (AUC), is also the highest among that of
all approaches [8]. Based on the optimal properties of
the LR, we had previously developed a FROC approach
for risk prediction on a large number of common
genetic variants [9].
The FROC approach uses a computationally efficient
algorithm, the forward selection algorithm, to search a
large number of genetic predictors for an optimal risk
prediction model. The forward selection algorithm
starts with a null model and gradually adds new pre-
dictors to the model to improve its accuracy. In each
step, the forward selection algorithm searches all loci
for a locus that most significantly improves the predic-
tion model. The whole selection process continues
until adding a new predictor no longer increases the
prediction accuracy. A series of prediction models,
with different levels of model complexity, are thus
obtained. Among these models, the first model with
only one predictor is the simplest model, and it has
the lowest AUC value; the last model, which has the
largest number of predictors, is the most complex
model, and it has the highest AUC value. Although the
more complex models tend to have an estimated clas-
sification accuracy that is higher, they are more likely
to overfit the data when there are more risk groups.
We therefore used 10-fold cross-validation to identify
the best model with the appropriate complexity, and
we used that as our final model. Assuming that the
best model selects K loci, which consist of Mk
multilocus genotypes, we calculate the likelihood ratio
LRl
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where D and D denote disease status and nondisease
status, respectively. Each individual who carries a parti-
cular type of Mk multilocus genotype is assigned an LR
value. Based on the ranks of the LR values, we can form
an optimal ROC curve and calculate its corresponding
AUC value:
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where ND and ND are the number of case subjects
and control subjects, respectively. The kernel function ψ
is given by:
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CROC approach
The FROC approach was proposed for risk prediction
research on common variants. When both common and
rare variants exist, the FROC approach hardly selects
rare variants because of their low frequency, which
could lead to low accuracy of the prediction model. To
deal with both common and rare variants, we have
extended the FROC approach and are introducing the
CROC approach here. The CROC adopts a multistage
collapsing procedure to collapse rare variants into
pseudo-common variants and then uses the forward
selection algorithm of the FROC approach to search
both common and pseudo-common variants for the best
prediction model.
The development of the multistage collapsing proce-
dure is based on the ideas of Li and Leal [6]. Similar to
the forward selection algorithm, the collapsing proce-
dure selects rare variants in a stepwise manner and then
collapses them into a pseudo-common variant. To illus-
trate the method, we assume that (k − 1) rare variants
are selected in the previous (k − 1) steps and then col-
lapsed into a pseudo-common variant. The pseudo-com-
mon variant is defined by:
I
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measured by its AUC value. In step k,w es e a r c ht h e
remaining rare variants for one locus that increases the
AUC value most significantly and collapse it into the
pseudo-common variant. The procedure keeps collap-
sing new rare variants into the pseudo-common variant
until the AUC value stops increasing. A pseudo-com-
mon variant is thus formed.
We repeat the collapsing procedure on the remaining
rare variants and generate a set of pseudo-common var-
iants. The multistage collapsing procedure stops when
there are no rare variants left in the data. One of the
advantages of using a multistage collapsing procedure
instead of the original collapsing procedure is that it
could potentially consider bidirectional effects. The for-
ward selection algorithm is then used to search both
common variants and pseudo-common variants for an
optimal risk prediction model. Because the pseudo-com-
mon variants have a higher frequency, they are more
likely to be selected by the forward selection algorithm,
which could result in increased accuracy of the predic-
tion model.
Results
We evaluated the performance of the CROC approach
using the simulated Genetic Analysis Workshop 17
(GAW17) mini-exome sequencing data. The data are
composed of 697 individuals, in which 209 individuals
make up the case group. Thirty-seven candidate genes
were selected based on the simulation results provided.
There are 533 SNPs in the candidate genes, including
both disease susceptibility and noise loci. The MAFs of
these SNPs range from 0.00072 to 0.45122. Among
those, 400 SNPs are rare variants (MAF < 0.01). Using
the GAW17 data, we investigated whether the accuracy
of the risk prediction model could be improved by con-
sidering rare variants in the analysis. An additional ana-
lysis was also conducted to compare the performance of
the CROC and FROC approaches.
Risk prediction considering rare variants
We started the analysis by forming a risk prediction
model on all common variants. To assess the accuracy
improvement by adding rare variants, we also built a
risk prediction model using all genetic variants. In all,
200 replicates were used for the analysis. Risk prediction
models were built based on the first 100 replicates,
using both the CROC and FROC approaches; they were
then evaluated on the remaining 100 replicates. The rea-
son for evaluating the model on a separate replicate is
to ensure that the rare variants are evaluated. Because
of the small sample size of the data set, rare variants are
commonly carried by one individual or by a small num-
ber of individuals. If we split the data into training and
testing data sets, then rare variants present in the train-
ing data set will likely be absent in the testing data set
and therefore cannot be validated. Using two replicates
ensures the presence of the same rare variants in both
data sets. However, we should note that the estimation
might be biased because of the potential correlation
between two replicates.
The accuracy of the risk prediction models was aver-
aged over 100 replicates and is summarized in Table 1.
The results show that the prediction model built on
both common and rare variants using the CROC
approach (AUC = 0.605) attains higher accuracy than
the one built on common variants alone using either the
CROC or the FROC approach (AUC = 0.585). The
CROC approach is equivalent to the FROC approach
when only common variants are considered. However,
the CROC approach outperforms the FROC approach
when both common and rare variants are considered
(Table 1). With additional rare variants, the risk predic-
tion model built by the FROC approach maintains the
same level of accuracy (AUC = 0.585), whereas the
model built using the CROC approach has improved
accuracy (AUC = 0.605). In addition, the CROC
approach requires less computation time (1058 s) than
the FROC approach does (1911 s).
Comparison of CROC and FROC approaches
From Table 1, we also see that the performance of the
two approaches is dependent on how many common or
rare variants are involved in the analysis. The FROC
and CROC approaches are comparable when only com-
mon variants are analyzed. However, the CROC
approach outperforms the FROC approach when both
common and rare variants are considered in the analy-
sis. To further investigate the performance of the two
approaches, we gradually dropped out the common var-
iants while keeping all the rare variants in the analysis.
We applied the two approaches on subsets with a
reduced number of common variants and obtained the
averaged AUC values and their 95% confidence inter-
vals. The results are summarized in Figure 1. We found
that the CROC approach outperformed the FROC
approach in all cases, especially with the lower number
Table 1 Accuracy improvement in the CROC approach by
adding rare variants
Common SNPs only All SNPs
FROC CROC FROC CROC
Mean of AUC value 0.585 0.585 0.585 0.605
SD of AUC value 0.048 0.048 0.048 0.023
Running time (s) 821 821 1,911 1,058
The CROC approach is equivalent to the FROC approach when only common
variants are considered.
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only rare variants were used in the analysis, the CROC
approach attained a much higher AUC value (0.603)
than the FROC approach (0.524).
Discussion
Next-generation sequencing technology is anticipated to
be a powerful tool for uncovering novel genetic variants
associated with complex disease, particularly for those
variants with a low frequency. The rare variants identi-
fied through future whole-genome sequencing studies, if
confirmed to have functional importance, may provide
novel insights into underlying pathological and etiologi-
cal processes. Yet, even if they are merely predictive and
without functional importance, these rare variants can
still be harnessed into clinical translational research
applications. By incorporating these rare variants into
current risk prediction models, we can predict disease
outcomes more accurately.
We developed a CROC approach for future risk pre-
diction research on sequencing data. The approach
extends the previously developed FROC approach to
deal with both common and rare variants by using a
multistage collapsing procedure. The idea of collapsing
was originally introduced in genetic association studies
to deal with both common and rare variants. We have
now integrated those ideas into the CROC approach for
risk prediction research on sequencing data. By applying
the approach on the simulated mini-exome sequencing
data, we demonstrated the advantage of using both
common and rare variants in risk prediction research.
However, in this application, limited improvement was
gained when additional rare variants were combined
with common variants. This may be because rare var-
iants account for only a small proportion of phenotype
variation. However, in a different scenario, rare variants
might contribute significantly to phenotype variation.
Therefore we artificially decreased the influence of com-
mon variants. When the number of common variants
was decreased, we found that significant improvement
could be attained by considering additional rare variants.
The accuracy of the risk prediction models can be
Figure 1 Comparison of the CROC and FROC approaches. We plotted AUC values against the different number of common variants included
in the data. AUC values and their corresponding 95% confidence intervals were calculated based on 100 testing replicates.
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dictors and gene-environment interactions. We ran an
additional analysis including the environment risk pre-
dictors and found that the prediction accuracy was sig-
nificantly improved (data not shown).
We considered only candidate genes in our analysis.
Current risk prediction studies commonly adopt this
strategy. However, for high-dimensional risk prediction
research using millions of SNPs, variable selection
becomes important. Although a forward selection algo-
rithm is incorporated into the CROC approach, it could
still be subject to false positives when dealing with
whole-genome sequencing data. More sophisticated
selection algorithms will be needed to deal with a large
number of common and rare variants.
Conclusion
We have developed a CROC approach for risk predic-
tion analysis on sequencing data. By applying this new
approach to the simulated GAW17 mini-exome sequen-
cing data, we have illustrated that current risk predic-
tion models built on common variants can be further
improved by considering additional rare variants. In
addition, we compared the CROC approach with the
existing FROC approach. The CROC approach outper-
formed the FROC approach, especially when a large
proportion of the considered variants were rare.
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